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Abstract 
 
Characterization of DAI during MCMV Infection 
 
Vanessa J. Landsteiner, M.A. 
The University of Texas at Austin, 2015 
 
Supervisor:  Jason W. Upton 
 
 
Pathogen recognition initiates host cell defense mechanisms including activation 
of the innate immune system in an effort to clear an infection. As a survival mechanism, 
viruses have developed potent strategies to evade the host response. Viruses that persist 
for the life of their host, such as herpesviruses, are particularly adept at modulating host 
innate immunity to benefit the virus.  Previous work has shown that receptor interacting 
protein kinase (RIP)3-dependent programmed necrosis is a critical host response toward 
murine cytomegalovirus (MCMV) infection, and this pathway is actively inhibited during 
infection by the MCMV M45 gene product, also known as vIRA.  IRA inhibits the 
association of RIP3 with the DNA-dependent activator of interferon regulatory factors 
(DAI/ZBP-1), clearly implicating DAI in this pathway. In addition to programmed 
necrosis, DAI has also been implicated in the antiviral immune response toward 
herpesviruses. However, the mechanisms by which DAI mediates these functions during 
viral infection remain largely unexplored.  Using the MCMV model, we have further 
characterized the role of DAI in the host innate immune response to MCMV infections. 
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Chapter 1: Introduction 
Viruses are obligate intracellular parasites that can infect all organisms.  They 
require access to host cell machinery in order to produce progeny virus.  This necessity 
causes a battle between host and virus to evolutionarily outwit their opponent for better 
survival.  Mammalian antiviral defense is a multifaceted immune response initiated 
through pattern recognition receptors (PRRs) of the innate immune system that recognize 
microbial pathogen-associated molecular patterns (PAMPs) (Broz and Monack, 2013).  
Binding of a PAMP by a PRR initiates signal cascades inducing downstream 
transcription factors, such as NF-κB and AP-1, that coordinate to upregulate expression 
of antiviral effectors, including type I interferon (IFN) and the pro-inflammatory 
cytokines, chemokines, and costimulatory molecules that activate the host innate and 
adaptive immune responses.  Chemokines are secreted to warn neighboring cells to 
prepare for invasion and inflammatory cytokines recruit phagocytes to clear infection and 
activate the programmed cell death pathway to combat invaders. 
In contrast to other free-living pathogenic microbes such as bacteria and fungi that 
produce unique products like lipopolysaccharide or flagellin, viruses produce few 
specific components that distinguish them from their hosts. For this reason, many host 
mechanisms for sensing viruses tend to focus on the detection of virus-associated nucleic 
acids that are found outside of the nucleus (Kumar et al., 2009; Paludan and Bowie, 2013; 
Wu and Chen, 2014). Nucleic acid-sensing receptors can be either membrane-bound or 
localized to the cytosol and each receptor possesses either an RNA or DNA recognition 
motif. Host cells present toll-like receptors (TLRs) on their cell surface and in endosomes 
to sample extracellular contents for pathogens.  Cells also contain cytosolic receptors 
such as AIM2-like receptors (ALRs), NOD-like receptors (NLRs) and RIG-I-like 
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receptors (RLRs) that, upon sensing nucleic acids, evoke an innate immune response to 
limit viral and bacterial infections by initiating antiviral, pro-inflammatory, and 
programmed cell death pathway (Wang et al., 2014). 
 
1.1 FORMS OF PROGRAMMED CELL DEATH 
As a host defense mechanism, programmed cell death can be an effective strategy 
for limiting the success of intracellular pathogens.  Cell death can be accomplished via 
several methods primarily apoptosis and programmed necrosis.   
1.1.a Apoptosis 
Apoptosis is the systematic dismantling of the cell without invoking an 
inflammatory response, and is defined by characteristic chromosomal fragmentation, 
nuclear condensation, and membrane blebbing (Hengartner, 2000). Apoptosis is 
dependent upon the sequential and coordinated activity of specific cysteine-proteases 
called caspases that are activated by intrinsic stimuli resulting in the loss of mitochondrial 
integrity or via extrinsic stimuli, such as PRR or ligation of death receptors, release of 
cytochrome c and formation of the apoptosome (Bratton and Salvesen, 2010).  
Phagocytes dispose of the dismantled components of the apoptotic bodies.   
While apoptosis is an effective host defense to limit viral infection, most viruses 
have adapted to encode numerous cell death suppressors (Best, 2008; Lamkanfi and 
Dixit, 2010). Large DNA viruses like herpesvirues, poxviruses, and adenoviruses have 
numerous anti-apoptotic strategies.  Molluscum contagiosum virus (MCV), Equine 
herpesvirus 1 (EHV-1), Cytomegalovirus (CMV) and Kaposi’s sarcoma-associated 
herpesvirus (KSHV) each encode viral FLICE-like inhibitory proteins (vFLIP) proteins 
(MC159, E8, vICA and K13 respectively) that block the activation of caspase-8 delaying 
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apoptosis (Mocarski et al., 2012).  Herpes simplex virus (HSV) expresses an immediate 
early protein, ICP0, that in addition to inhibiting interferon regulatory factors, also 
prevents the production of RNase L to stave off the degradation of viral RNAs as a 
mechanism to prevent activation of cytosolic nucleic acid sensors (Sobol and Mossman, 
2006). MCMV uses two proteins, vMIA and vIBO (m38.5 and m41.1 respectively) to 
target BAX and BAK to directly block mitochondrial apoptosis, and encodes a third 
protein, vICA (M36), that inhibits caspase 8 (reviewed in Everett and McFadden, 1999; 
Kaiser et al., 2013; Tait and Green, 2012).  
 
1.1b Caspase-8-independent Programmed Necrosis 
In an effort to limit viruses which encode apoptotic cell death suppressors, host 
cells have evolved secondary death pathways that work independent of caspase-8 
(Handke et al., 2012).  Programmed Necrosis is characterized by cell swelling, organelle 
damage and plasma membrane rupture that spills cytoplasmic contents into the 
extracellular space resulting in extensive inflammation (Kaiser et al., 2013).  When 
caspase 8 function is compromised, programmed necrosis is initiated, and requires the 
activity of Receptor-interacting protein kinase (RIP)3 (Cho et al., 2009; He et al., 2009; 
Upton et al., 2010; Zhang et al., 2009).  Death receptor (DR)-induced programmed 
necrosis (also called necroptosis) results in the formation of the necrosome, a complex of 
RIP3 and a related kinase, RIP1 (Festjens et al., 0000; Meylan and Tschopp, 2005).  
RIP1-RIP3 interact via a specific protein-protein interaction motif, known as a RIP 
homotypic interaction motif (RHIM) (Sun et al., 2002) that is critical for programmed 
necrosis (Cho et al., 2009; Mocarski et al., 2012; Upton et al., 2010). Other RHIM-
dependent, RIP3-containing complexes, including RIP3 with DAI (Kaiser et al., 2008) or 
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the TIR-domain containing adapter-inducing interferon beta (TRIF) (Meylan et al., 
2004), also lead to necroptosis in response to pathogen infections (Sridharan and Upton, 
2014)(Figure 1). These complexes sponsor the association of RIP3 with MLKL, a 
downstream effector, to mediate programmed necrosis.   
 
1.2 VIRAL DEFENSES BLOCK PROGRAMMED NECROSIS 
 Like inhibitors of apoptosis, some viruses encode inhibitors of programmed 
necrosis.  The MCMV M45 gene encodes the viral inhibitor of RIP activation (vIRA) 
which inhibits DR or TRIF-dependent apoptosis, necroptosis, and virus-induced 
programmed necrosis within 8-12 hours post-infection (Mack et al., 2008; Upton et al., 
2008; Upton et al., 2010).  vIRA contains a RHIM and binds RIP3 during infection to 
inhibit necrosis (Upton et al., 2010).  Recombinant MCMV viruses encoding vIRA with a 
mutation in the RHIM are unable to suppress premature cell death in normal host cells 
and are entirely attenuated in normal and immunocompromised hosts.  Moreover, in 
RIP3-deficient mice, mutant M45 MCMV virus replication is normalized to levels 
comparable to WT MCMV virus, demonstrating that the death pathway induced by 
mutant M45 encoding MCMV infection is RIP3-dependent (Upton et al., 2008; Upton et 
al., 2010). MCMV’s vIRA protein has been shown to disrupt the RIP3-DAI interaction, 
inhibit NF-κB activation and RIP3 autophosphorylation when DAI is overexpressed 
(Kaiser et al., 2008; Rebsamen et al., 2009). In the absence of vIRA RHIM-mediated 
inhibition, RIP3 interacts with DAI during MCMV infection. DAI-deficient mice restore 
mutant vIRA MCMV virulence in vivo similar to RIP3-deficient mice (Upton et al., 
2012). Although significant attention has been devoted to understanding the mechanisms 
of RIP3 activation and activity during necroptosis, there are many unanswered questions 
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regarding how RIP3-dependent virus-induced programmed necrosis is initiated and how 
DAI functions in that pathway.   
 
1.3 STRUCTURE OF DAI 
DAI (also known as ZBP1 or DLM-1) was first described as a gene upregulated in 
mouse tumor stromal cells (Fu et al., 1999) and later identified as a cytosolic DNA sensor 
of the immune system.  It is believed to be involved in signaling to initiate IFN-β 
expression in the innate immune responses by activating the interferon-regulatory factor 
(IRF)-3 and NF-κB pathways (Takaoka et al., 2007).  DAI is constitutively expressed in 
many cell types and tissues, including spleen, thymus, liver, lung and heart as well as in 
macrophages, and like many other pathogen sensors, it can be robustly induced by 
interferons (Fu et al., 1999).   
DAI is comprised of two nucleic acid binding domains, two or possibly three, 
RHIM-like repeats (Figure 2), and a C-terminal domain believed to associate with the 
IRF3 transcription factor (Figure 3) (Takaoka et al., 2007).  However, how these features 
influence DAI function is only beginning to be elucidated.  DAI is unique in that it 
contains two Z-DNA binding domains, Zα and Zβ, on the N-terminus of the protein.  
These motifs bind Z-form DNA, and only two host other proteins are known to contain 
Z-DNA binding domains, the adenosine deaminase ADAR1 (Brown et al., 2000; Herbert 
et al., 1997) and PZK protein kinase containing Z-DNA binding domains (Rothenburg et 
al., 2005). Vaccinia virus encodes an innate immune modulator designated E3L, that 
contains a Z-binding domain, to overcome the host response (Herbert et al., 1997).  
However, the function of the Z-DNA binding domains is unclear.  Crystal structures from 
human DAI revealed that the Zα domain strongly resembles other Z-DNA binding 
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domains with long continuous α-helixes (Schwartz et al., 2001), but the Zβ domain, 
while maintaining the conserved core residues (Y145, N141 and W161), has a unique 
structure that distinguishes it from other Z-DNA binding domains.  The Zβ kinked helix 
blend presents a unique binding mode to interact with the DNA backbone of B-DNA and 
convert it to Z-form DNA (Ha et al., 2008).  The two DNA binding motifs of DAI can 
independently bind Z-DNA, although substrate binding is greatly increased when they are 
linked in tandem (Deigendesch et al., 2006). Interestingly, naturally occurring isoforms 
of DAI lack the Zα domain, and have different subcellular localization (Pham et al., 
2006).  Moreover, mutation to core DNA-binding residues of the Zα domain change the 
subcellular localization from fine, diffused puncta throughout the cytoplasm to large 
accumulations of mutant DAI in proximity of stress granules as seen naturally with ΔZα 
isoforms (Deigendesch et al., 2006). Despite significant attention to the DNA binding 
function of Z-DNA binding motifs, there remains little insight into their natural function 
in vivo.   
DAI has been suggested to recognize cytosolic DNA and facilitate activation of 
both TANK-binding kinase 1 (TBK1) and IRF3 to induce expression of IFN-β during 
herpes simplex virus infection in murine fibroblasts (Furr et al., 2011; Takaoka et al., 
2007).  DAI may require its Z-DNA binding domains to be fully activated in vivo and it is 
purported to dimerize to activate the immune system (Wang et al., 2008).  Similar 
activation of interferon occurs during human CMV infection in human foreskin 
fibroblasts (DeFilippis et al., 2010a; DeFilippis et al., 2010b). Both the nucleic acid 
binding domains and C-terminal domain of DAI have been suggested to be necessary for 
downstream IRF3-mediated gene expression in response to cytosolic synthetic DNA and 
HSV-1 infection in murine L929 cells (Takaoka et al., 2007; Wang et al., 2008).  
However, truncation of the Zα domain of human DAI did not affect the expression of 
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IFNβ when stimulated with synthetic poly dA:dT in HEK293T cells (Lippmann et al., 
2008), and DAI was entirely dispensable for innate responses in other human cell types, 
suggesting species or cell type dependent function for DAI.  Moreover, DAI-deficient 
mice have normal innate and adaptive immune responses to B-form DNA and DNA 
vaccination, suggesting DAI is dispensable for the host immune response to cytosolic 
DNA (Ishii et al., 2008).   
In contrast, as described above, DAI has also been shown to participate in RIP3 
RHIM-dependent programmed necrosis pathway during MCMV infection (Upton et al., 
2010, 2012). In addition to its unique nucleic acid binding motifs, DAI contains three 
RHIM-like repeats, RHIMs A, B, and C (Kaiser et al., 2008).  RHIM A and RHIM B of 
DAI have been shown to bind other RHIM-containing protein, and RHIM A appears to 
be the dominant functional RHIM mediating the majority of binding to RIP1 and/or RIP3 
to activate NF-κB (Kaiser et al., 2008; Rebsamen et al., 2009). RHIM C is less well 
conserved (Figure 2), and is considered a putative RHIM as it has not been shown to be 
functional (Kaiser et al., 2008). At present, only RHIM A of DAI has been implicated in 
MCMV-induced programmed necrosis (Upton et al., 2012). 
 
1.4 RATIONALE FOR STUDY 
Since DAI-RIP3 complex is targeted by vIRA to abrogate cell death, infections 
with WT MCMV and M45mutRHIM MCMV can be used as a natural system to further 
characterize the domains of DAI during MCMV infection. While it has been clearly 
established that DAI plays an important role in MCMV-induced programmed necrosis 
throught it’s interaction with RIP3, a complete understanding the contribution of DAI’s 
different domains during MCMV-induced necrosis is lacking. Moreover DAI has been 
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classified as a DNA sensor and implicated in activation of NF-κB and IFN production, 
however it's role in these host responses against MCMV infection is also unknown.  This 
study aims to 1) undertake a thorough structure-function analysis of DAI in order to gain 
insights into the mechanism of its role in virus-induced programmed necrosis, and 2) 
define DAI’s contribution to host innate immune signaling during MCMV infection.  
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Chapter 2: Experimental Design and Methods 
2.1 EXPRESSION VECTOR CONSTRUCT MUTAGENESIS  
Wild type murine DAI isoform 1 DNA was cloned into pCMV10-3XFLAG 
vector (Sigma-Aldrich) using the BglII/XbaI restriction sites to introduce a N-terminal 
epitope tag. Mutations to DAI were introduced using specific primers (Table 1) using 
overlap extension PCR.  The N-terminal epitope-tagged DAI was then cloned into the 
pQCXIH vector (Clonetech) using the NotI/BamHI restriction sites. All construct 
mutations were verified through sequencing with specific primers (Table 2). 
 
2.2 CRISPR KNOCKOUT SVEC CELL LINES  
Endogenous DAI was targeted for knockout using the RNA-guided CRISPR/Cas9 
system. Guide RNAs were designed using the Zhang Lab target finder database 
(crispr.mit.edu) and CRISPR construct design by DKFZ German Cancer Research Center 
(e-crisp.org) for target sites at the 29th or 69th amino acid located in exon 2 of DAI. These 
positions correspond to nucleotides 173216940-173216959 (29) and 173216853-
173216835 (69) of the NCBI Mus mucsculus Annotation Release 105 (NC_000068.7).  
Two oligo 60-mers (Table 3) were annealed and extended with Fusion polymerase 
(Thermo Scientific) to generate a 100bp product.  gRNACloning vector (Mali et al., 
2013) (a gift from George Church (Addgene plasmid # 41824)) was linearized with AflII. 
The linearized vector and oligo fragment were cloned by Gibson assembly. The 
gRNA_Cloning Vector, hCas9 Vector (Mali et al., 2013) (a gift from George Church 
(Addgene plasmid # 41815)), and the puromycin resistance containing pQXCIP vector 
were co-transfected into SVEC4-10 cells. 24-hours post-transfection cells were selected 
for puromycin resistance using 2μg/ml puromycin. Following outgrowth, single cells 
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were subcloned by limiting dilution. Clonal populations were surveyed for absence of 
DAI expression via Western blot using the rabbit anti-ZBP clone 887 antibody (Karayel 
et al., 2009) (a gift from Tillman Burckstummer and Giulio Superti-Furga, CeMM).  
Sequence specific mutations were confirmed by sequencing of PCR amplified genomic 
DNA.  Fragments were cloned into pCR-Blunt vector (Invitrogen), transformed into 
DH5α competent cells and selected for Kanamycin resistance.  DNA was prepared and 
sequenced using the ZBP Surveyor primer set (Table 3).  
 
2.3 STABLE-EXPRESSING DAI MUTANT CELL LINES 
pQCXIH retroviral expression vectors containing FLAG-tagged WT or DAI-
mutants (Figure 3) were transfected along with VSV-G, TAT and JK3 vectors into 
HEK293T cells using GenJet InVitro Transfection Reagent (Signagen) as described in 
manufacturer’s protocol.  Cell media was changed 18 hours post-transfection and 
supernatant media was collected at 24 and 48 hours post-transfection.  Supernatants were 
stored at -80°C then thawed, passed through a 0.45 μm filter, and applied along with 
8μg/ml polybrene to a monolayer of SVEC4-10 CRISPR KO cells. Transduction was 
repeated twice over 2-day period. Transduced cells were allowed to recover for 24 hours 
then selected with 400 μg/ml hygromycin for 3 days then reduced to 200 μg/ml for 
maintenance treatment. DAI expression was confirmed by immunoblotting for FLAG 
epitope.  
 
2.4 CO-IMMUNOPRECIPITATION 
Media was removed and monolayer cells were washed with PBS then lysed with 
NP-40 lysis buffer (150mM NaCl, 50mMTris pH8.0, 1% NP40, Complete protease 
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inhibitor). Cells were collected and further lysed by five passes through a 26G needle.  
Lysates were centrifuged for 20 minutes at 12,000 RPM at 4°C. Supernatant was 
transferred to new tube and the appropriate equilibrated magnetic agarose-congugated 
Anti-HA (Pierce) or Anti-FLAG® M2 (Sigma-Aldrich) beads were added.  Samples were 
agitated, end-over-end, overnight at 4°C. The supernatant was removed post-incubation 
and beads were washed extensively with lysis buffer. Beads were boiled for 5 minutes at 
95°C in 2xSDS Sample buffer. Protein lysates were then separated electrophoretically via 
SDS-PAGE gels and subjected to immunoblotting. 
 
2.5 IMMUNOBLOTTING 
Protein lysates were electrophoretically separated on 8% SDS-PAGE gels and 
transferred via semi-dry electrophoretic transfer cell onto nitrocellulose blotting 
membranes for immunoblot detection. Membranes were blocked with a 5% Non-fat milk-
TBST solution for 1 hour, washed with TBST then treated with the indicated antibodies 
for 1hr to overnight.  Primary antibodies were removed, membranes were washed 3 times 
with TBST solution and either subjected to ECL reagent for antibody detection or treated 
with a secondary antibody.  Antibodies used in these studies were: Mouse anti-FLAG-M2 
peroxidase conjugate (Sigma-Aldrich), rabbit anti-cMyc- peroxidase conjugate (Sigma-
Aldrich), rabbit anti-DAI clone 887 (Karayel et. al, 2009 European Journal Immuno. 
39(7) 1929-36.) (a gift from Tillman Burckstummer and Giulio Superti-Furga, CeMM), 
rabbit anti-mouse RIP3 (Imgenex), mouse anti-β-actin, cloneAC-74 (Sigma-Aldrich), 
peroxidase  labeled anti-Mouse IgG (H+L) (Vector Laboratories, Inc.), and peroxidase  
labeled anti-Rabbit IgG (H+L) (Vector Laboratories, Inc.). ECL Prime Western blotting 
reagents (Amersham) were used for antibody detection on autoradiography film. 
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2.6 CELL VIABILITY ASSAYS 
SVEC CRISPR Stable cell lines expressing mutant DAI proteins were seeded at a 
density of 5x103 cells/well in 96-well plates and grown overnight. Cells were treated for 
death pathway responses with combinations of the following reagents: dimethyl sulfoxide 
(DMSO), 25 ng/ml mouse TNF-α (PeproTech), 50 μM/ml zVAD-fmk (Enzo Life 
Sciences), 5μg/μl cyclohexamide (Acros Organics) and/or 30 μM Necrostatin-1 
(Calbiochem). Cell viability was also assessed under MCMV infection conditions as 
follows: either 50 μl medium for mock treated or infected with 50 μl WT K181 MCMV 
or M45mutRHIM MCMV inoculum containing 10 pfu/cell (MOI: 10) and incubated 18-
hours under normal cell culture conditions. Cell viability was assessed using 50 μl 
CellTiter-Glo Luminescent Cell Viability Assay (Promega) as previously described 
(Upton et al., 2010; Upton et al., 2012). A Synergy microplate reader (Bio-Tek) was used 
to record the endpoint luminescence.  
 
2.7 SAMPLE GENERATION 
SVEC CRISPR Stable cell lines expressing mutant DAI proteins were grown 
under normal cell culture conditions. Cells were seeded in a series of five sets of 6-well 
plates at a density of 3x105 cells/well and grown overnight. Cells were either mock 
treated or infected with WT MCMV at MOI of 5 and harvested at indicated time points. 
Mock-infected cells were harvested at 0.16 hours post-treatment and MCMV-infected 
cells were harvested at 0.16 hours, 3 hours, 6 hours, and 9 hours post-infection. At 
harvest, cells were washed with PBS then preserved with 1ml RNA Later solution 
(Ambion) and stored at 4°C awaiting RNA isolation. 
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2.8 RNA ISOLATION 
Plates were removed from 4°C, RNA Later solution was removed, and cell 
monolayer was washed twice with PBS. Cells were harvested and total RNA was isolated 
using the MirVana Total RNA Isolation kit (Ambion) according to manufacturer’s 
protocol. 
 
2.9 REVERSE-TRANSCRIPTASE PCR 
1000 ng total RNA was DNase treated for 1 hour at 37°C then used to generate 
cDNA via the Superscript III First-Strand Synthesis System for RT-PCR (Invitrogen). 
The kit was used with the supplied oligo dT20 primers according to manufacture’s 
protocol.  
 
2.10 QUANTITATIVE REVERSE-TRANSCRIPTION PCR  
qPCR was conducted on StepOnePlus Real-Time PCR System (Applied 
Biosystems) using Universal SYBR Green Supermix (BIO-RAD Laboratories) with 
primer sets for the target genes IL-6 and IFN-β previously described in (Kaiser et al., 
2008; O’Donnell et al., 2005). Primer sequences are found in Table 4. Cycling conditions 
were as follows: 50°C for 2 minutes and 95°C for 2 minutes then 40 cycles at 95°C for 15 
seconds and 60°C for 1 minute. Melt curves were determined by 95°C for 15 seconds, 
60°C for 1 minute then temperature increase at 3° increments to 95°C and 95°C hold for 
15 seconds. 
Target gene mRNA expression levels were normalized to the expression of 
GAPDH. The relative mRNA expression fold changes were calculated by the ΔΔCt 
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method. Data graphed compared to initial timepoint (T0.16) for each mutant construct and 
also compared each mutant against the corresponding EV at each time point.  
 
2.12 STATISTICAL ANALYSES 
Statistical significance was evaluated by using the student’s T-test. P-value of 
p<0.05 was considered to be statistically significant. 
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Chapter 3: Results 
3.1 CONSTRUCTION OF DAI MUTANTS 
In order to address the role of DAI in the host response to MCMV infection, a 
panel of truncation and point mutants of murine DAI was constructed (Figure 3). To 
investigate the role of the DNA-binding motifs, truncations removing the N-terminal Zα 
domain (amino acids 1-75- ΔZα) and both the Zα and Zβ domains (amino acids 1-150 - 
ΔZαβ) were constructed.  Additionally, point mutations were made altering the 
conserved DNA binding residues of the Zα and Zβ motifs from asparagine to aspartate 
and tyrosine to alanine (N46D/Y50A – mZα; N122D/Y126A – mZβ), similar to 
previously constructed human DAI mutants that abrogate DAI binding to DNA 
(Deigendesch et al., 2006). The C-terminal region of DAI has been purported to mediate 
Interferonβ induction by recruiting TBK1/IRF (Takaoka et al., 2007). To examine the 
contribution from the C-terminal region, a truncation was made removing the last 100 
amino acids from the C-terminus, similar to a previously constructed DAI mutant 
(Takaoka et al., 2007) (ΔC). Takaoka and colleagues found that DNA binding required 
a.a.155-233, which they termed “D3,” which lies C-terminally adjacent to the Zβ DNA-
binding domain and encompasses RHIM A (Kaiser et al., 2008; Takaoka et al., 2007).  
To further explore the activity of the “D3” region (Takaoka et al., 2007) both of the DNA 
binding domains and the C-terminal region of DAI were removed (ΔZαβ ΔC). 
Current dogma suggests RHIM A is a major contributor of virus-induced cell 
death but does not dismiss a possible role for RHIM B. To monitor involvement of RHIM 
B in MCMV-induced programmed necrosis and confirm RHIM A activity, four alanine 
substitution mutations were made to the core residues of the RHIM (Figure 2) 
independently in either RHIM A (mRA) or RHIM B (mRB) and in tandem (mRAB). This 
mutageneisis strategy has been previously used to define the roles of RHIMs (Sun et al., 
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2002; Upton et al., 2010; Upton et al., 2012).  To further solidify RHIM A as a major 
contributor of cell death, a series of “RHIM swap” mutations were generated to test 
positional specificity of RHIM activity. RHIM A sequence was exchanged in place of 
RHIM B in WT DAI to create a mutant DAI with two identical RHIM A motifs lacking 
RHIM B (RA-RA). Additional mutation was introduced into the original RHIM A 
domain to render a mutant DAI with one functional RHIM A domain in the RHIM B 
position (mRA-RA). Similarly, RHIM B was exchanged for RHIM A generating a 
mutant lacking RHIM A but containing two RHIM B motifs (RB-RB), and four alanine 
substitution mutations were added to disable the primary RHIM B motif (RB-mRB), 
Lastly, a DAI mutant was designed to switch the RHIM A motif with the RHIM B motif 
to generate a mutant containing functioning RHIM A and RHIM B domains in their 
opposing location (RB-RA). Figure 3 shows a schematic representation of the described 
mutants of DAI.  The expression of these mutants proteins were confirmed by western 
blot (Figure 4, left panel), and all were shown to express to comparable levels.   
 
3.2 CHARACTERIZATION OF MUTANT DAI-RIP3 BINDING 
As RIP3 binding is critical for DAI-mediated MCMV-induced programmed 
necrosis (Upton et al., 2012), we used the constructed DAI mutants (Figure 3) to 
determine the role of each domain in interaction with RIP3.  As previously shown (Kaiser 
et al., 2008; Rebsamen et al., 2009), WT DAI robustly interacts with RIP3 in transient 
transfection assays, whereas mRA DAI fails to co-immunoprecipitate with RIP3 (Figure 
4). Consistent with the importance of RHIM A to the interaction, mRAB failed to bind 
RIP3.  DAI mRB and mRC co-immunoprecipitated RIP3 as efficiently as WT DAI, 
indicating that they are not significant contributors to the DAI-RIP3 interaction (Figure 
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4).  Similarly, neither specific mutations in the N-terminal DNA binding domains, nor 
truncations of the N- and/or C-terminus of DAI prevented DAI from co-
immunoprecipitating RIP3, indicating that the RHIM containing central portion of DAI is 
sufficient to bind RIP3. Due to a labeling error, human mZβ was used instead of murine 
mZβ DAI. As expected, human mZβ still efficiently coimmunoprecipitated with murine 
RIP3. Murine Zβ resembles the human form of DAI encoding the same core binding 
residues as human DAI, and in a similar location. However, the linker space between Zα 
and Zβ is 20 amino acids longer in human (Ha et al., 2008; Schwartz et al., 2001). 
Regardless, it is fully expected that murine mZβ binds RIP3, and this is currently being 
confirmed.  The DAI RA-RA and mRA-RA mutants pulled down RIP3 as efficiently as 
WT DAI, while RB-RB and RB-mRB failed to efficiently interact with RIP3, further 
solidifying RHIM A as the sole critical interacting motif in the RIP3-DAI interaction. 
Interestingly, DAI RB-RA, where the positions of RHIM A and B are swapped within the 
DAI protein, remained capable of co-immunoprecipitating RIP3 (Figure 4).   Together, 
these results indicate that RHIM A of DAI is necessary to mediate RIP3 binding.   
 
3.3  CONSTRUCTION AND CHARACTERIZATION OF STABLE CELL LINES EXPRESSING 
MUTANT DAI  
To investigate the role of DAI in MCMV-induced programmed necrosis, we 
generated a cell line in which endogenous DAI was knocked out and reconstituted with 
the mutant DAIs described above (Figure 3).  This strategy was employed to ensure 
endogenous WT DAI would not skew results and allow the investigation of each specific 
domain in isolation.  Moreover, a comparable reconstitution strategy was previously used 
to demonstrate the role of DAI RHIM A in necrosis (Upton et al., 2012).  The 
CRISPR/Cas9 system was employed to target sequence within the second exon of DAI to 
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yield a knockout cell line, and the knockouts were generated in SVEC4-10 murine 
endothelial cells.  These cells were selected because they are sensitive to MCMV-induced 
programmed necrosis, and constitutively express RIP3 and DAI (Upton et al., 2010; 
Upton et al., 2012).  Following selection and subcloning, DAI defective SVEC lines 29-
11 and 69-3 were shown to be deficient in DAI expression by Western blot compared to 
either parental SVEC4-10 or 29-2 control cells (Figure 5).  Sequencing confirmed the 
introduction of mutations, which result in the truncation and subsequent elimination of 
DAI expression (Figure 6).  29-11 and 69-3 were then used to generate a panel of cell 
lines stably-expressing the FLAG-tagged WT and mutant DAI alleles described in Figure 
3.  Western blotting confirmed expression of each DAI mutant, as well as expression of 
RIP3 (Figure 7).   
 
3.4 CHARACTERIZATION OF DAI IN VIRUS-INDUCED CELL DEATH AND TNF-INDUCED 
NECROPTOSIS 
Upon confirmation that stable cell lines expressed both RIP3 and the introduced 
DAI mutants, we next assessed the function of each DAI mutant during MCMV-induced 
programmed necrosis.  SVEC-DAI Cell lines were infected with either WT or 
M45mutRHIM MCMV and survival was assessed, as previously described (Upton et al., 
2010; Upton et al., 2012).  As expected, empty vector control (EV) reconstituted SVEC 
cells, which lack DAI expression, were insensitive to MCMV-induced programmed 
necrosis, while WT DAI expressing cells were as sensitive to this death pathway as the 
control SVEC4-10 cell line 29-2, which express endogenous DAI (Figure 5). SVECs 
reconstitution with mRA remained insensitive to death (Figure 8), consistent with 
previous reports that DAI RHIM A is necessary for MCMV-induced programmed 
necrosis (Upton et al., 2012).   Double mutant mRAB, lacking both RHIM A and RHIM 
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B, as well as RB-RB and RB-mRB, which lack RHIM A, all fail to sensitize SVECs to 
MCMV-induced programmed necrosis, similar to mRA (Figure 8), further confirming the 
critical role of RHIM A in necrosis.  Surprisingly, SVECs reconstituted with RA-RA or 
mRA-RA, which both contain and intact RHIM A sequence and bind RIP3, were 
relatively insensitive to MCMV-induced programmed necrosis, suggesting that RHIM A 
alone is not sufficient to mediate this pathway.  Conversely, but equally surprising, mRB 
reconstituted SVECs were hypersensitive to MCMV-induced programmed necrosis 
(Figure 8), which may indicate that RHIM B could function as a negative regulator of 
programmed necrosis. mZα, ΔZα, or ΔC DAI sensitized cells to MCMV-induced death 
at levels comparable to mRB, indicating that deletion or mutation of the Zα domain or 
deletion of the C-terminus of DAI is dispensable.  Additionally, mZβ, mZαmZβ, and 
ΔZαmZβ DAI also sensitize cells to death during infection.  These results suggest 
MCMV-induced programmed necrosis may not require DNA binding by DAI in murine 
endothelial cells.   However, deletion of the Zβ domain in the context of ΔZαβ and 
ΔZαβΔC mutants, both of which retain the ability to bind RIP3 (Figure 4), partially or 
completely rescues from death, suggesting some feature of the Zβ region, independent of 
DNA– binding may be required to mediate virus-induced programmed necrosis.  DAI-
reconstituted cells were dying by RIP3-dependent, MCMV-induced programmed 
necrosis since treatment of infected cells with necrostatin 1 (Nec-1), a potent and 
selective inhibitor of RIP1 kinase activity (Degterev et al., 2005), did not influence virus 
induced death, as previously described (Upton, 2010#35).   As controls, we also tested 
the panel of reconstituted cell lines for TNF induced necroptosis and apoptosis (Figure 9). 
DAI is not involved in TNF induced death, and consistently all of the above described 
cell lines, irrespective of their DAI status showed poor viability as compared to DMSO 
treated controls, when assayed for necroptosis (Figure 9A) or apoptosis (Fig 9B). Nec-1 
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rescued all of these cell lines from necroptotic death (Figure 9C). Interestingly, we 
noticed mRB and ΔC strongly sensitized cells to death when exposed to only zVAD or 
cycloheximide (Fig 9E,F), suggesting that RHIM B and the C-terminal region might 
negatively regulate DAI function. Similarly, all alleles lacking or mutated in the Zα 
region (mZα, ΔZα, mZα mZβ, and ΔZα mZβ) modestly sensitize cells to death in 
response to zVAD alone, again suggesting Zα may play a regulatory role in DAI 
function.  Taken together, the results described above establish these cell lines as a valid 
tool to interrogate DAI’s role in programmed necrosis and indicate that DAI RHIM A is 
necessary, but not sufficient, to mediate MCMV-induced programmed necrosis, that 
additional portions immediately adjacent to the Zβ domain are necessary, and that DAI 
DNA-binding may not be required.   
 
3.5 ASSESSING DAI-DEPENDENT IFN AND NF-ΚB ACTIVATION DURING MCMV 
INFECTION 
To further explore the role of DAI in expression of IFN and NF-κB, we evaluated 
SVEC4-10 cells stably expressing DAI mutants to determine its contribution to these 
pathways.  Initial experiments showed transfection of DAI-reconstituted SVEC4-10 cells 
with poly dA:dT showed an enhancement of IFNβ transcription compared to EV controls 
(Figure 10).  This result is consistent with prior studies suggesting DAI mediates 
activation of IFN in response to cytosolic DNA (Takaoka et al., 2007).  To extend these 
studies and assess the role of DAI in these pathways during MCMV infection, we 
infected the panel of WT and mutant DAI-reconstituted SVEC4-10 cell lines with WT 
MCMV at a high multiplicity, and determined mRNA levels of IFNβ and IL-6, an NF-κB 
responsive gene, by qPCR at various times post infection.  Preliminary studies indicated 
that IFNβ and IL-6 levels peaked in infected parental SVEC4-10 cells within the first 9 
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hours post infection (data not shown).  Surprisingly, there were no statistically significant 
differences found in IL-6 or IFNβ between EV and WT DAI-expressing SVECs during 
MCMV infection (p > 0.05) at the times assessed (Figure 11A, C).    Similar results were 
obtained from all mutant DAI-reconstituted cell lines tested (Figure 11A-D).  These 
results would suggests that DAI is not a significant contributor to the IFN or NF-κB 
pathways during MCMV infection. 
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Chapter 4 Discussion 
The work described here provides new insight into the mechanism of DAI 
function during MCMV infection. Previous work exploring the role of DAI in host 
responses used HSV-1, a human virus, in murine cell lines, as well as synthetic 
transfected DNA to elicit responses (Lippmann et al., 2008; Takaoka et al., 2007; Wang 
et al., 2008), leaving the interpretation of DAI function subject to artifacts of these 
unnatural systems.    We developed a system of genetic knock-out and reconstitution of 
WT and mutant DAI expression in a biologically relevant context to systematically 
evaluate individual domains for their contribution to RIP3-mediated, virus-induced 
programmed necrosis.  We further used this system to evaluate the potential role of DAI 
in pro-inflammatory and antiviral signaling during viral infection in a cell system 
originating from its natural host.   
 The data presented here corroborates previous findings (Kaiser et al., 2008; 
Rebsamen et al., 2009) that identified RHIM A of DAI as an important interacting motif 
necessary for RIP3 binding.  RIP3 interaction with DAI can be maintained even when the 
position of RHIM A is shifted within the protein (Figure 4), although DAI encoding 
multiple copies of the RHIM A sequence show no evidence additional RIP3 binding.   
Truncating significant portions of the N- and C-termini of DAI does not diminish RIP3 
interaction, and only mutation of RHIM A abrogates complex formation in transient 
assays.  Together, these results clearly define RHIM A as necessary for DAI-RIP3 
interaction.  It is worth noting that the RB-RA mutant appears to show reduced binding to 
RIP3 (Figure 4), compared to RA-RA and mRA-RA mutants, suggesting that additional 
spatial considerations of the RHIMs within DAI warrant further investigation.  One 
potential test of this hypothesis would be to generate additional DAI swap mutants, 
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including RHIM A replacing RHIM C location to ensure that the RIP3-DAI interaction is 
sequence specific regardless of the RHIM motif location.  
One significant unexpected finding from this work was that although RHIM A of 
DAI is necessary for RIP3 interaction, it alone is not sufficient to mediate MCMV-
induced programmed necrosis. The ΔZαβ and ΔZαβ ΔC truncation mutants contain an 
intact, correctly positioned RHIM A that is capable of interacting with RIP3 (Figure 4), 
however knock-out cells reconstituted with either were not sensitized to MCMV-induced 
necrosis (Figure 8). Similarly, the RHIM-swap mutations RA-RA and mRA-RA, while 
able to interact with RIP3, also failed to confer sensitivity to MCMV-induced necrosis 
(Figure 8).  This is a surprising result in that RA-RA contains an intact, properly 
positioned RHIM A and binds RIP3 as efficiently as WT DAI, further supporting the idea 
that the spatial parameters of RHIMs within DAI influence their function.  Together, 
these results demonstrate that RHIM A is critical for RIP3 binding, but additional 
structural or sequence features of DAI are necessary to mediate this death pathway.   
To investigate the role of other domains in virus induced necrosis, we tested 
additional mutants designed to eliminate DAI binding to DNA (Figure 3) (Deigendesch et 
al., 2006).  Interestingly, sensitivity to cell death was enhanced by mutants lacking the Zα 
DNA-binding domain (ΔZα) or when resides critical for DNA binding within the Z 
binding motifs were mutated (mZα, mZβ, and mZα mZβ) but not when both Zα and Zβ 
domains were removed (ΔZαβ) (Figure 9), implying that DNA binding to the Z-DNA 
binding motifs is not required for MCMV-induced cell death.  Notably, the D3 region of 
DAI, as described by Takaoka and colleagues (Takaoka et al., 2007), is necessary for 
binding synthetic DNA in vitro.  This region does not include the Z-DNA binding 
domains of DAI, but does encompass RHIM A, and is similar, but not identical, to the 
ΔZαβ DAI described here (Figure 3).   ΔZαβ DAI removes a.a.1-175, whereas the DAI-
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ΔN1 described by Takaoka and colleagues to define the D3 region, removes a.a.1-154 of 
DAI.  To investigate this phenomenon further, DNA-binding assays are warranted to 
confirm whether ΔZαβ retains DNA binding capabilities and if DAI-ΔN1 is sufficient to 
sensitize cells to MCMV-induced programmed necrosis.    
Another unanticipated result from this work is that mRB DAI enhances MCMV-
induced programmed necrosis nearly 3-fold.  The significant increase of cell death in 
cells containing mutant RHIM B but not when RHIM A is lacking (as in mRAB, RB-RB, 
and RB-mRB), suggests that RHIM B could possibly serve as a negative regulator of 
RHIM A. In our studies of the sensitivity of these cell lines to TNF-mediated necroptosis 
and apoptosis (Fig 9B), we found that mRB similarly increased sensitivity to zVAD or 
CHX alone. Curiously, in addition, we also observed that deletion of the regions of Zα 
and C-terminus also modestly sensitizes these cells to both treatments. Some 
accumulating evidence indicates that mutation of RHIM B enhances DAI-dependent 
activation of NF-κB (data not shown, (Rebsamen et al., 2009)), which in turn could 
enhance TNF production and secretion.  However, it is also possible that mutations in the 
Zα, RHIM B, or C-terminus of DAI alter its structure or binding partner repertoire to 
affect some presently unappreciated facet of DAI signaling.   
Due to conflicting reports as to the role of DAI in mediating type-I IFN and NF-
κB responses to cytosolic DNA (Takaoka, 2007#133;Wang, 2008#130;Lippmann, 
2008#129; Kaiser, 2008#37), we sought to clarify its role in these pathways during 
MCMV infection.  Using our knock-out/reconstitution system, we found there were no 
significant differences between cells expressing no DAI and those expressing any mutant 
from our extensive panel.  While we saw extensive variation in biological replicates that 
could be attributed to technical difficulties, our results indicate that DAI is not a major 
force in inducing NF-κB or IFN during MCMV infection of murine endothelial cells.   
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However, we have clearly shown it plays a significant role in mediating antiviral 
programmed necrosis. Although DAI may be involved in the host response during 
infection, it is not a dominant contributor to the induction of antiviral or pro-
inflammatory cytokines during viral infection of a natural host.  It is worth noting that 
most results indicating a role of DAI in these pathways were obtained in systems utilizing 
transfection of synthetic DNA or zoonotic infections (Lippmann et al., 2008; Takaoka et 
al., 2007; Wang et al., 2008).  Our results support the notion that DAI may be a redundant 
or species-specific sensor of microbial infection.   
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Figures and Tables 
 
 
 
 
 
Figure 1: Role of RHIM-containing proteins in programmed necrosis death 
signaling pathways. TLR, death receptors, or viruses induce signaling by RHIM-
containing adapters that activates programmed necrosis. RIP3 associates with either 
TRIF, RIP1 or DAI through homotypic interactions.  MLKL is activated by the RHIM-
RHIM protein complex and relays the signal downstream to initiate programmed 
necrosis.  MCMV protein vIRA inhibits RIP3-DAI mediated signaling during infection 
by binding RIP3 to prevent complex formation. Abbreviations: RHIM, RIP homotypic 
interaction motif; TLR3, Toll-like receptor 3; RIP, receptor-interacting protein; TRIF, 
TIR domain-containing adapter-inducing interferon-β; MCMV, murine cytomegalovirus; 
MLKL, mixed lineage kinase domain-like; vIRA, viral inhibitor of RIP activation. 
Adapted from Sridharan & Upton, 2014. 
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Figure 2: Schematic representation of RHIM-containing proteins. The RHIMs of 
human (Hs) and mouse (Mm) DAI and RIP3 kinase were aligned along with M45 gene of 
MCMV. Shaded regions represent a 60% identify threshold on the BLOSUM62 matrix. 
Adapted from Kaiser et. al, 2008. 
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Figure 3: Schematic representing DAI mutants used in these studies. DAI contains 
two N-terminal Z-DNA binding domains (labeled Zα, Zβ) and three RHIM-like regions 
(labeled RA, RB, RC). Mutations are indicated with an ✖. Deletions are represented by 
missing icons. Amino acid positions are annotated next to deletions. 
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Figure 4: DAI-RIP3 interaction requires RHIM A. HEK293T cells transiently 
expressing 6MYC-RIP3 and the indicated 3Flag-DAI mutants. Cell lysates were 
subjected to immunoprecipitation (IP) with anti-Flag magnetic beads, and analyzed by 
immunoblot with anti-MYC, anti-FLAG, and anti-β-Actin. Whole cell lysate (WCL) left 
panel; FLAG IP right panel. 
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Figure 5: Characterization of SVEC CRISPR Knockout cell lines deficient in DAI. 
Cell lysates were prepared from the indicated parental, control, or knockout cell line, and 
analyzed by immunoblot to detect endogenous DAI and β-Actin. 
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Figure 6: Schematic representation of DAI mutations introduced through 
CRISPR/Cas9 system. Nucleic acid sequences of 29-2 control, 29-11 KO or 69-3 KO 
cells aligned to murine DAI WT (gene ZBP1). Lavender shading highlights the two-base 
pair deletion in 29-11 and blue shading highlights the single base insertion in 69-3 cell 
line. Red shading highlights the resulting in-frame stop codon introduced by the 
mutations. 
 
 
 
WT ZBP1  GGTTCCTCCCCAGACAATCTGGAGCAAAAGATCCTGCAGGTGTTGAGCGATGACGGCGGC 
29-2  GGTTCCTCCCCAGACAATCTGGAGCAAAAGATCCTGCAGGTGTTGAGCGATGACGGCGGC 
29-11  GGTTCCTCCCCAGACAATCTGGAGCAAAAGATCCTGCAGGTGTTGAGCGATGACGGCGGC 
69-3  GGTTCCTCCCCAGACAATCTGGAGCAAAAGATCCTGCAGGTGTTGAGCGATGACGGCGGC  
 
WT ZBP1  CCTGTGAAGATTGGCCAGCTGGTGAAGAAATGCCAAGTGCCCAAGAAAACCCTCAATCAA 
29-2  CCTGTGAAGATTGGCCAGCTGGTGAAGAAATGCCAAGTGCCCAAGAAAACCCTCAATCAA 
29-11  CCTG--AAGATTGGCCAGCTGGTGAAGAAATGCCAAGTGCCCAAGAAAACCCTCAATCAG 
69-3  CCTGTGAAGATTGGCCAGCTGGTGAAGAAATGCCAAGTGCCCAAGAAAACCCTCAATCAA  
 
WT ZBP1  GTCCTTTACCGCCTGAAGAAGGAGGACAGAGTGTCCTCCCCAGAGCCTGCAACATGGAGC 
29-2  GTCCTTTACCGCCTGAAGAAGGAGGACAGAGTGTCCTCCCCAGAGCCTGCAACATGGAGC 
29-11  GTCCTTTACCGCCTGAAGAAGGAGGACAGAGTGTCCTCCCCAGAGCCTGCAACATGGAGC 
69-3  GTCCTTTACCGCCTGAAGAAGGAGGACAGAGTGTCCTCCCCAGAGCCTGCAACATGGAGC  
 
WT ZBP1  ATAGG-CGGGGCTGCTTCTGGAGATGGGGCTCCTGCAATCCCTGAGAACTCCAGTGCCCA 
29-2  ATAGG-CGGGGCTGCTTCTGGAGATGGGGCTCCTGCAATCCCTGAGAACTCCAGTGCCCA 
29-11  ATAGG-CGGGGCTGCTTCTGGAGATGGGGCTCCTGCAATCCCTGAGAACTCCAGTGCCCA 
69-3  ATAGGGCGGGGCTGCTTCTGGAGATGGGGCTCCTGCAATCCCTGAGAACTCCAGTGCCCA  
 
WT ZBP1  GCCTAGCCTTGGTAATCTGTCATGTAGGCAGAGCAGACCCCCCACACACACTAAGCTCTC 
29-2  GCCTAGCCTTGGTAATCTGTCATGTAGGCAGAGCAGACCCCCCACACACACTAAGCTCTC 
29-11  GCCTAGCCTTGGTAATCTGTCATGTAGGCAGAGCAGACCCCCCACACACACTAAGCTCTC 
69-3  GCCTAGCCTTGGTAATCTGTCATGTAGGCAGAGCAGACCCCCCACACACACTAAGCTCTC 
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Figure 7: Mutant DAI reconstituted in SVEC4-10 CRISPR KO. Immunoblot analysis 
of WCL to detect Flag-tagged DAI mutants, endogenous RIP3, and β-actin from SVEC4-
10 CRISPR KO cell lines reconstituted with Flag-DAI mutants. Clone 29-11 (left panel) 
and clone 69-3 (right panel).  
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Figure 8: Cell death responses of SVEC4-10 CRISPR KO cell lines. A) Viability of 
indicated SVEC4-10 CRISPR KO reconstituted DAI mutant cell lines during MCMV 
infection (MOI=10). B) Viability of indicated SVEC4-10 CRISPR KO reconstituted DAI 
mutant cell lines with and without Nec-1 (30μM) treatment to inhibit RIP1 kinase 
activity. (n=3-6).  
 
 
EV WT
29
-2 
co
ntr
ol
mR
A
mR
B
mR
AB
RA
-R
A
mR
A-
RA
RB
-R
B
RB
-m
RB mZ
α
mZ
β
mZ
α m
Zβ ΔZ
α
ΔZ
α m
Zβ
ΔZ
αβ ΔC
ΔZ
αβ
ΔC
0
20
40
60
80
100
Vi
ab
ili
ty
(%
 W
T 
in
fe
ct
ed
 c
el
ls
)
A
EV WT mR
A
mR
B
mZ
b
ΔZ
α
ΔZ
αβ ΔC
0
20
40
60
80
100
120
Vi
ab
ili
ty
(%
 v
eh
ic
le
 tr
ea
te
d 
ce
lls
)
Mock
+Nec-1
B
 34 
 
 
 
Figure 9: SVEC4-10 stably expressing DAI Mutants remains sensitive to TNF-
induced necroptosis and apoptosis. Viability of mutant DAI-expressing SVEC4-10 
stable cell lines after treatment with A) TNF (25ng/ml) and zVAD-fmk (50μM) to induce 
necroptosis. B) TNF (25ng/ml) and cyclohexamide (5μg/μl) to induce apoptosis C) TNF, 
zVAD-fmk and Nec-1 (30 μM) to inhibit RIP1-dependent cell death. Viability of mutant 
DAI-expressing SVEC4-10 stable cell lines after control treatments with D) TNF alone. 
E) zVAD-fmk alone. F) CHX alone. (n=3-12). 
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Figure 10: Interferon-β induction after poly dA:dT stimulation. SVEC4-10 knockout 
cells reconstituted with EV Flag control or WT DAI. Interferon-β induction measured by 
qPCR 9hrs post-treatment. (n=1). 
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Figure 11: NF-κB and Interferon-β induction during MCMV infection. SVEC 29-11 
knockout cells reconstituted with the indicated DAI mutants were infected with WT 
MCMV (MOI=5). Cells harvested at post-infection timepoints: 10 minutes (T0.16 in 
white), 3 hours (T3 in light grey), 6 hours (T6 in dark grey), and 9 hours (T9 in black) 
post-infection. Samples were normalized to T0.16 and normalized timepoints are displayed 
for each DAI mutant indicated. EV and WT samples shown in B and D are the same data 
as in A and C respectively. (n=3-4). A) IL-6 induction in mutant DAI cells. B) IL-6 
induction in DAI truncation cells. C) IFN-β induction in mutant DAI cells. D) IFN-β 
induction in DAI truncation cells.  
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Table 1.  DAI Mutagenesis Primers 
Primer 
name Sequence Description
VL-005 GAGAGGATCCAGCAGAAGCTCCTGTTGACTTGAGCA Murine DAI orf to go into p3xFLAG-10 vector (Forward)
VL-006 CGTAGGTACCTCATTGCTTGCTCAGTCCTGTGTC Murine DAI orf to go into p3xFLAG-10 vector (Reverse)
VL-007 TCCATTGCCAATTCAAACGCCGCCGCGGCTGCACACGGGAATGTCATAG mRHIM A - Sense
VL-008 CTATGACATTCCCGTGTGCAGCCGCGGCGGCGTTTGAATTGGCAATGGA mRHIM A - Complement
VL-009 TCCTTGCTCCAACAAGCGGCAGCTGCCCACCACAACGAGATGAGCCTC mRHIM B - Sense
VL-010 GAGGCTCATCTCGTTGTGGTGGGCAGCTGCCGCTTGTTGGAGCAAGGA mRHIM B - Complement
VL-011 CGTAGGTACCTCATAGAAAGCAGGATTTGATGTGGACTGTCTGG dC - Complement
VL-016 GAGAGGATCCAGGGGCTCCTGCAATCCCTGAGAAC Zalpha truncation- Sense
VL-017 GAGAGGATCCAGGCCAAGACATAGCTCATTCTGGA Zalpha-beta truncation - Sense
VL-018 TCCTGCTTTCTAGAGGACGCCGCCGCTGCAAACGGCAACAAGATGACC mRHIM C - Sense
VL-019 GGTCATCTTGTTGCCGTTAGCAGCGGCGGCGTCCTCTAGAAAGCAGGA mRHIM C - Complement
VL-020 GTGCCCAAGAAAACCCTCGATCAAGTGCTAGCCCGCCTGAAGAAGGAGG mZalpha - Sense
VL-021 CCTCCTTCTTCAGGCGGGCTAGCACTTGATCGAGGGTTTTCTTGGGCAC mZalpha - Complement
VL-022 AGCCAAAGAAGTCGACCCACTGCTAGCCTCCATGAGAAATAAGCA mZbeta - Sense
VL-023 TGCTTATTTCTCATGGAGGCTAGCAGTGGGTCGACTTCTTTGGCT mZbeta - Complement
VL-024
ATCTCTATAGCCAATTCAAACGCCATCCAGATTGGTCACGGGAATGTCAT
AAGCCTCGTGGGGGATGCAG
RHIM A replaces RHIM B for RA-RA or mRA-RA constructs 
- Sense
VL-025
TATGACATTCCCGTGACCAATCTGGATGGCGTTTGAATTGGCTATAGAGA
TGTAGATGTACTGAGCTCCG
RHIM A replaces RHIM B for RA-RA or mRA-RA constructs 
- Complement
VL-026
ATGGACAAGTCCTTGCTGCAGCAAGTGCAGCTTGGCCACCACAACGAGAT
GGTAAGAGAGAAAGCCTGTGGTGAG
RHIM B replaces RHIM A for RB-RB or RB-mRB constructs 
-Sense
VL-027
CATCTCGTTGTGGTGGCCAAGCTGCACTTGCTGCAGCAAGGACTTGTCCA
TGTGGCTGTTGGCTCCTTGTTGG
RHIM B replaces RHIM A for RB-RB or RB-mRB constructs 
-Complement  
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Table 2. DAI Sequencing Primers 
 
Primer nameSequence Description
VL-001 AATGTCGTAATAACCCCGCCCCGTTGACGC CMV30 primer for 3XFlag-CMV-10 plasmid -Sense
VL-002 TATTAGGACAAGGCTGGTGGGCAC CMV24 primer for 3XFlag-CMV-10 plasmid - Complement
VL-003 ACGCCATCCACGCTGTTTTGACCT pQCXIH - Sense
VL-004 AAGCGGCTTCGGCCAGTAACGTTA pQCXIH - Complement
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Table 3. CRISPR/Cas9 Primers 
Primer nameSequence Description
s-aa-69-S
TTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACACCGGCAACATGG
AGCATAGGCG CRISPR/Cas9 guide to 69th amino acid - Sense
s-aa-69-C GACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAACCGCCTATGCTCCATGTTGCC CRISPR/Cas9 guide to 69th amino acid - Complement
s-aa 29-S TTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACACCGCCAGCTGGCCAATCTTCACA CRISPR/Cas9 guide  to 29th amino acid  - Sense
s-aa 29-C GACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAACTGTGAAGATTGGCCAGCTGGC CRISPR/Cas9 guide  to 29th amino acid - Complement
ZBP 
Surveyor 
FWD
CATAGTACACAGGGCAGGCTGTATAC ZBP Surveyor sequencing - Sense
ZBP 
Surveyor 
REV
CTCAGATTTGAAGCCAAGCCTCGT ZBP Surveyor sequencing - Complement
 
  
 40 
Table 4. RT qPCR Primers 
Primer nameSequence Description
HS58 TCCAGTTGCCTTCTTGGGAC IL-6 Sense
HS59 GTACTCCAGAAGACCAGAGG IL-6 Complement
IFNb Fwd GGAGATGACGGAGAAGATGC IFN-b Sense
IFNb Rev CCCAGTGCTGGAGAAATTGT IFN-b Complement
GAPDH Fwd TGTTCCTACCCCCAATGTGT GAPDH Sense
GAPDH Rev CCCAGTGCTGGAGAAATTGT GAPDH Complement   
 41 
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